Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2014
09/17/2014EP2778156A1 Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states
09/17/2014EP2778155A1 2-aminopyridine derivatives useful as kinase inhibitors
09/17/2014EP2777403A1 Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring
09/17/2014EP2776565A1 Methods and compositions for treating diseases, disorders or injury of the nervous system
09/17/2014EP2776430A1 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists
09/17/2014EP2776427A1 Modulators of atp-binding cassette transporters
09/17/2014EP2776418A1 Inhibitors of phosphodiesterase type 10a
09/17/2014EP2776394A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
09/17/2014EP2776393A1 Nampt inhibitors
09/17/2014EP2776131A1 Composition for treating or preventing neurodegenerative disorders
09/17/2014EP2776059A2 Pharmaceutical compositions containing proteases and methods for the treatment of lysosomal storage diseases
09/17/2014EP2776058A1 Apotransferrin for the treatment of brain stroke
09/17/2014EP2776035A1 Compositions and methods for reduction of amyloid-beta load
09/17/2014EP2776022A1 New treatment for neurodegenerative diseases
09/17/2014EP2776018A1 Pkc activators and combinations thereof
09/16/2014US8835618 Mutations of the parkin gene
09/16/2014US8835500 Pharmaceutical formulations of amyloid inhibiting compounds
09/16/2014US8835487 Method of treating multiple sclerosis
09/16/2014US8835482 Substituted indazole and aza-indazole derivatives as gamma secretase modulators
09/16/2014US8835438 Method of treating memory/learning dysfunctions caused by schizophrenia with lurasidone
09/16/2014US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
09/16/2014US8835434 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
09/16/2014US8835403 Algin oligosaccharides and the derivatives thereof as well as the manufacture and the use of the same
09/16/2014US8834897 Methods for using tetanus toxin for beneficial purposes in animals (mammals)
09/16/2014CA2777532C Stable rasagiline composition
09/16/2014CA2727830C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma
09/16/2014CA2649845C Terphenyl derivatives for treatment of alzheimer' s disease
09/16/2014CA2454644C Cannabinoid liquid formulations for mucosal administration
09/15/2014CA2846402A1 Methods and device for treating opioid addiction
09/15/2014CA2809686A1 Use of minocycline for therapeutic treatment of acute spinal cord injuries
09/12/2014WO2014138484A1 Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
09/12/2014WO2014138003A1 Compositions comprising an immunosuppressive drug and/or neural stem cells and methods of using same for the treatment of neurodegenerative diseases and/or disorders
09/12/2014WO2014137849A1 Pentacyclic pyridoindolo[b,e]azepine derivatives and uses thereof
09/12/2014WO2014136730A1 Oxidation reaction with excellent conversion rate
09/12/2014WO2014136717A1 Transdermally absorbable pharmaceutical composition
09/12/2014WO2014136305A1 Morphinan derivative
09/12/2014WO2014136118A1 Treatment of post-traumatic stress disorder with melanocortin receptor antagonist
09/12/2014WO2014136075A1 H3 antagonists containing phenoxypiperidine core structure
09/12/2014WO2014135529A1 Mixture of fatty acids for use in the treatment of inflammatory pathologies
09/12/2014WO2014134776A1 Compounds inhibiting leucine-rich repeat kinase enzyme activity
09/12/2014WO2014134774A1 Compounds inhibiting leucine-rich repeat kinase enzyme activity
09/12/2014WO2014134772A1 Compounds inhibiting leucine-rich repeat kinase enzyme activity
09/12/2014WO2014134692A1 Extract of hippeastrum papilio rich in galanthamine
09/11/2014US20140256652 Polypeptides Involved In Immune Response
09/11/2014US20140255493 Extrudate and methods of using said extrudate
09/10/2014EP2774935A1 Improved neurturin molecules
09/10/2014EP2774926A1 Morphinan derivative
09/10/2014EP2774914A1 N-benzylaniline derivative and uses thereof
09/10/2014EP2774612A1 4-Methylpyrazole formulations
09/10/2014EP2773748A1 Midbrain dopamine (da) neurons for engraftment
09/10/2014EP2773645A1 Imidazopyridazine compounds
09/10/2014EP2773643A1 Pak inhibitors for the treatment of fragile x syndrome
09/10/2014EP2773609A2 Nicotinic receptor non-competitive modulators
09/10/2014EP2773382A1 Co-activation of mtor and stat3 pathways to promote neuronal survival and regeneration
09/10/2014EP2773361A1 Method for improving executive function
09/10/2014EP2773344A1 Delivery systems for improving oral bioavailability of fenobam, its hydrates, and salts
09/10/2014EP2773341A2 Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders
09/10/2014EP2773339A1 Composition for improving neuropsychological test battery score
09/10/2014EP2773338A1 Improving recognition
09/10/2014EP2773337A1 Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitors
09/09/2014US8829011 2-aminopyrimidine compounds as serotonin receptor modulators
09/09/2014US8829006 Compounds
09/09/2014US8828974 Substituted propane phosphinic acid derivatives
09/09/2014US8828973 Compounds as receptor modulators with therapeutic utility
09/09/2014US8828934 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
09/09/2014US8828404 Vaccine and method for treatment of neurodegenerative diseases
09/09/2014US8828359 Particulate materials
09/09/2014CA2789236C Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
09/09/2014CA2644441C Treatment of neurodegenerative diseases
09/09/2014CA2596755C Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
09/09/2014CA2591766C Tetrahydroquinoline analogues as muscarinic agonists
09/04/2014WO2014134380A1 Administration of gamma hydroxybutyrate with monocarboxylate transporters
09/04/2014WO2014134349A1 Methods of modulating dlk stability
09/04/2014WO2014134341A1 Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
09/04/2014WO2014134306A1 Heterocyclic inhibitors of the sodium channel
09/04/2014WO2014134221A1 Compositions and methods for treatment in parkinson's disease patients
09/04/2014WO2014132218A1 Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters
09/04/2014WO2014132215A1 Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters
09/04/2014WO2014132210A1 Alpha-synuclein antibodies and uses thereof
09/04/2014WO2014131855A1 Novel compounds as dual inhibitors of phosphodiesterases and histone deacetylases
09/04/2014WO2014131825A1 Pharmaceutical formulations comprising quetiapine and escitalopram
09/04/2014WO2014109725A3 Use of glycyl glutamine against depression
09/04/2014WO2013179264A4 Compounds modulating astrocytic release of substances through connexins and pannexins and treatment of psychiatric disorders
09/04/2014WO2013134085A8 Inhibitors of beta-secretase
09/04/2014US20140249166 Methods of treating patients suffering from movement disorders
09/04/2014US20140248700 Method of Differentiation of Morula or Inner Cell Mass Cells and Method of Making Lineage-Defective Embryonic Stem Cells
09/04/2014US20140248661 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
09/03/2014EP2772492A1 Use of an isoxazole derivative for the treatment of withdrawal symptom
09/03/2014EP2772484A1 Bicyclic heterocyclic compound
09/03/2014EP2772482A1 Azole derivative
09/03/2014EP2772481A1 Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof
09/03/2014EP2771367A1 Gigaxonin fusion protein and methods for treating giant axonal neuropathy
09/03/2014EP2771340A1 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
09/03/2014EP2771322A2 Novel trpv3 modulators
09/03/2014EP2771030A1 Compositions and methods for treatment of proteinopathies
09/03/2014EP2771021A2 Nmda receptor modulators and uses thereof
09/03/2014EP2770997A1 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1
09/03/2014EP2770988A1 New therapy for transthyretin-associated amyloidosis
09/02/2014US8822636 Peptides for activation and inhibition of δPKC
09/02/2014US8822519 Compound with agitation effect on peroxisome proliferator-activated receptor process for its preparation and use thereof
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 1833